Juan Echevarría

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study

Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 255 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Diagnosis of Leishmania Using the Polymerase Chain Reaction: a Simplified Procedure for Field Work

R Inga, Juan Echevarría, Alejandro Llanos‐Cuentas et al. · American Journal of Tropical Medicine and Hygiene · 1993 · 198 citations

Veterinary Medicine, Infectious Diseases, Molecular Biology +17

Effect of salt supplementation on amphotericin B nephrotoxicity

Javier Cieza, Juan Echevarría, Italo Biaggioni et al. · Kidney International · 1991 · 129 citations · Full text

Medicine, Nephrology, Nutritional Sciences +13

COMPARISON OF MEGLUMINE ANTIMONIATE AND PENTAMIDINE FOR PERUVIAN CUTANEOUS LEISHMANIASIS

E. M. Andersen, Alejandro Llanos‐Cuentas, MARIA LUZ-CJUNO et al. · American Journal of Tropical Medicine and Hygiene · 2005 · 100 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial

Jacob Lalezari, Gulam Latiff, Cynthia Brinson et al. · The Lancet HIV · 2015 · 68 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9